Skip to content

Cannabis: all studies

Page 42 of 288: studies 411 to 420 of 2,874, newest first. Back to the cannabis overview

Research

Cannabis use and psychosis among patients hospitalized in psychiatric wards in Lebanon: a retrospective chart review

Middle East Current Psychiatry November 13, 2023 Pia Maria Ghanimé, Zeinab Bazzi, Joseph Kazan et al.

Abstract Background Trends in cannabis use suggest a global increase in the past decade. Current evidence associates cannabis use with an increased risk of psychosis. This association has prompted a growing research interest in the association between cannabis use and psychiatric disorders, especially psychotic disorders. This study aims to gain a better understanding of the effect of cannabis...

The psychedelic effects of cannabis: A review of the literature

Journal of Psychopharmacology November 10, 2023 David Wolinsky, Frederick Streeter Barrett, Ryan Vandrey 16 citations

Cannabis and classic psychedelics are controlled substances with emerging evidence of efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been regarded as having psychedelic effects in contemporary literature, despite many examples of historical use along with classic psychedelics to attain altered states of consciousness. Research into the “psychedelic”...

The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain.

Journal of Cannabis Research November 9, 2023 Jussi Jylkkä, Aleksi Hupli, Aleksandra Nikolaeva et al.

Medical cannabis (MC) is increasingly used for chronic pain, but it is unclear how it aids in pain management. Previous literature suggests that MC could holistically alter the pain experience instead of only targeting pain intensity. However, this hypothesis has not been previously systematically tested. A retrospective internet survey was used in a sample of Finnish chronic pain patients (40...

DOI: 10.1186/s42238-023-00207-7 (opens in new tab) Full text (opens in new tab) Chronic pain Consciousness Experience Functionality +6

O uso de Cannabis como fator de risco para o desenvolvimento/progressão de quadros de Esquizofrenia: Uma revisão de literatura

Research, Society and Development November 4, 2023 João Marcelo Defanti Zonaro, Tiago Emanoel Melo Pereira, Renan Chaparro Rodrigues Alves Barbosa Coelho

Introdução: A Cannabis é a terceira substância psicoativa mais utilizada no mundo. Seu uso, além de outras comorbidades, tem impacto na saúde mental, com destaque para os quadros esquizofrênicos, uma vez que cerca de 26.6% desses pacientes sofrem do Transtorno pelo uso da Cannabis (TUC). O uso dessa droga é frequente em pacientes com desordens psicóticas, como a esquizofrenia e também parece...

DOI: 10.33448/rsd-v12i11.43869 (opens in new tab) Schizophrenia object-oriented programming Effects of cannabis

Subjective effects of simultaneous alcohol and cannabis versus alcohol-only use: A qualitative analysis.

Psychology of Addictive Behaviors November 2023 Jack T. Waddell, Jennifer E. Merrill, Sarah A. Okey et al.

Theoretical models of addictive behavior suggest that subjective effects serve as a mechanism through which substance use disorders develop. However, little is known about the subjective effects of simultaneous alcohol and cannabis use, particularly whether simultaneous use (a) heightens specific subjective effects or (b) is related to unique subjective effects relative to single-substance...

Self-Regulation of Driving Behavior Under the Influence of Cannabis: The Role of Driving Complexity and Driver Vision.

Human factors November 2023 Sonia Ortiz-Peregrina, Oscar Oviedo-Trespalacios, Carolina Ortiz et al.

This study analyzed the self-regulation behaviors of drivers under the influence of cannabis and its relationship with road complexity and some driver traits, including visual deterioration. Cannabis is the illicit drug most often detected in drivers; its use results in significant negative effects in terms of visual function. Self-regulation behaviors involve the mechanisms used by drivers to...

A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.

Psychiatry Research November 1, 2023 J. Groening, Emma Denton, Rimsha Parvaiz et al.

While the legal status and public perception of cannabis are currently changing in many countries, one of the important considerations from a public health viewpoint is its potential association with adverse health outcomes such as the development of psychosis. We conducted an umbrella review of systematic reviews and meta-analyses using the AMSTAR-2 to assess the quality of included reviews....

A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis

Frontiers in Psychiatry October 27, 2023 Aviv Weinstein 3 citations

There is increased risk of psychosis associated with cannabis use disorder and the interaction of THC with dopamine neurotransmission is complex. It is important to investigate the recovery from cannabis-induced psychosis and its effects on the brain’s dopamine neurotransmission. This study was to evaluate dopamine receptor D 2 availability in the striatum (caudate/putamen) in recently...

Chronic cannabis use in everyday life: Emotional, motivational, and self-regulatory effects of frequently getting high

October 13, 2023 Michael Inzlicht, Taylor Bridget Sparrow-Mungal, Gregory John Depow 1 citation preprint

Approximately 200 million people consume cannabis annually, with a significant proportion of them using it chronically. Using experience sampling, we describe the effects of chronically getting high on emotions, motivation, effort, and self-regulation in everyday life. We queried chronic users (N=260) 5 times per day over 7 days (3,701 observations) to assess immediate effects of getting high...

Determination of tetrahydrocannabinol and cannabidiol contents in Cannabis sativa L. samples in Togo using gas chromatography-mass spectrometry

Journal of Medicinal Plants Research October 9, 2023 Kodjo Eloh, Alfa Komi, Oudjaniyobi Simalou et al. 3 citations

Cannabis sativa L. is a widely used recreational drug in Togo, especially among young people. However, little is known about its chemical composition in Sub-Saharan Africa, and specifically in Togo. This study aimed to determine the levels of phytocannabinoids, specifically Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in cannabis samples collected from various towns in Togo using gas...